Achillion Pharmaceuticals, a developer of small molecule drugs, has received a Phase I Small Business Innovation Research, or SBIR, Grant from the National Read More >>

Achillion Pharmaceuticals, Inc., a biopharmaceutical company, has received a phase I small business innovation research grant (SBIR) Read More >>

SmallCapReview.com has been a leading site for information on small cap stocks, penny stocks and microcaps since 1999, to receive the free SmallCapReview n Read More >>

Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN), a leader in the discovery and development of small molecule drugs to combat the most chal Read More >>

Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN), a leader in the discovery and development of treatments for the most challenging infectio Read More >>

Achillion Pharmaceuticals, a developer of small molecule drugs, has reported a net loss of $6.73 million, or $0.25 per share, for the fourth quarter ended D Read More >>

***********************************************************************

Seeking higher-yielding returns? Interested in real-time trading ideas? Str Read More >>

Achillion Pharmaceuticals, Inc. (ACHN)

Expected next earnings release:

Announcement date: 5/13/2010 - Before Market

Earnings Quarter
          
            Read More
            >>
          
        

Achillion Pharmaceuticals, Inc. (ACHN)

Expected next earnings release:

Announcement date: 3/12/2010 - Before Market

Earnings Quarter
          
            Read More
            >>
          
        

Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN), a leader in the discovery and development of small molecule drugs to combat the most chal Read More >>

(Comment on this article at http://www.financialwire.net/2010/03/12/conference-calls-today-1205-1250-p-m-est/)

March 12, 2010 (FinancialWire) (In Read More >>

Achillion Pharmaceuticals, Inc. (ACHN)

Expected next earnings release:

Announcement date: 3/25/2010 - After Market

Earnings Quarter:
          
            Read More
            >>
          
        

The penny stock and small cap stock trading community at SmallCapNetwork.com has recently published outlooks for Incyte Corporation (NASDAQ:INCY), Zagg Inc. ( Read More >>

Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN), a leader in the discovery and development of treatments for the most challenging infectiou Read More >>

Achillion Pharmaceuticals, Inc. (ACHN)

Expected next earnings release:

Announcement date: 3/25/2010 - After Market

Earnings Quarter:
          
            Read More
            >>
          
        

Achillion Pharmaceuticals, Inc. (ACHN)

Expected next earnings release:

Announcement date: 3/25/2010 - After Market

Earnings Quarter:
          
            Read More
            >>
          
        

Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN), a leader in the discovery and development of small molecule drugs to combat the most chal Read More >>

Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN), a leader in the discovery and development of treatments for the most challenging infectiou Read More >>

Achillion Pharmaceuticals, Inc., a US-based biopharmaceutical company focused on developing treatments for infectious diseases, has Read More >>

Achillion Pharmaceuticals Inc. said Tuesday that it has raised $22.9 million from its recent sale of addit Read More >>

Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN), a leader in the discovery and development of treatments for the most challenging infectiou Read More >>

Achillion Pharmaceuticals, Inc. has signed a license agreement with GCA Therapeutics, Ltd. (GCAT) for Achillion's elvucitabine, a nu Read More >>

SmallCapReview.com has been a leading site for information on small cap stocks and penny stocks since 1999, to receive the free SmallCapReview newsletter v Read More >>

Achillion Pharmaceuticals has signed a licensing agreement for elvucitabine, the company's nucleoside reverse transcriptase inhibitor for the treatment of b Read More >>

Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) today announced the execution of a license agreement for elvucitabine, the Company's nucleo Read More >>

(Comment on this article at http://www.financialwire.net/2010/02/01/conference-calls-today-430-445-p-m-est-3/)

February 1, 2010 (FinancialWire) ( Read More >>

Skymark Research, a leading provider of small- and micro-cap independent investment research, today initiated coverage on Achillion Phar Read More >>

SmallCapReview.com has been a leading site for information on small cap stocks and penny stocks since 1999, to receive the free SmallCapReview newsletter v Read More >>

Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) today announced the nomination of a lead clinical candidate in its third proprietary progr Read More >>

Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN), a leader in the discovery and development of small molecule drugs to combat the most chal Read More >>

Achillion Pharmaceuticals, a developer of infectious disease treatments, has priced underwritten public offering of 10.27 million shares of its common stock Read More >>

Achillion Pharmaceuticals Inc. on Friday issued 10.28 million shares of its common stock at $2.08 per shar Read More >>

Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN), a leader in the discovery and development of treatments for the most challenging infectio Read More >>

Pharmaceutical company Achillion Pharmaceuticals Inc (Nasdaq:ACHN) said on Thursday that it is planning to launch a public offering of common stock and Read More >>

New Haven-based Achillion Pharmaceuticals Inc. said Thursday that it plans to make an initial public offer Read More >>

Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN), a leader in the discovery and development of treatments for the most challenging infectio Read More >>

Aureon Laboratories, Inc. today announced the appointment of Robert L. Van Nostrand as Executive Vice President and Chief Financial Officer Read More >>

(Comment on this article at http://www.financialwire.net/2010/01/13/achillion-announces-additional-positive-phase-to-treat-hepatitis-c/)

January Read More >>

StockPreacher.com announces an investment report featuring biopharmaceutical company Achillion Pharmaceuticals Inc. (Nasdaq:ACHN). The report incl Read More >>

DrStockPick.com tracks stocks daily and is pleased to offer its hot stock alerts. Investors can receive FREE Stock Alerts by visiting D Read More >>

Keep up with TimelessWealth's Market Watchlists at http://timelesswealth.net/dailywatch.html

Energy XXI Announces Major Discovery at Davy Jones Ult Read More >>

Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) today reported additional preliminary data from its on-going phase 1b clinical trial of AC Read More >>

Achillion Pharmaceuticals, Inc. (ACHN)

Expected next earnings release:

Announcement date: 3/25/2010 - After Market

Earnings Quarter:
          
            Read More
            >>
          
        

Achillion Pharmaceuticals, Inc. (ACHN)

Expected next earnings release:

Announcement date: 3/25/2010 - After Market

Earnings Quarter:
          
            Read More
            >>